CQM - the Unknown Risk in Electrosurgery

2009 ◽  
pp. 12-15 ◽  
Author(s):  
N. H. Nessler ◽  
M. Salchner
Keyword(s):  
Unknown Risk

Should we change the focus of health promotion in sexual health clinics?

Sexual Health ◽  
2010 ◽  
Vol 7 (4) ◽  
pp. 407 ◽  
Author(s):  
Rudiger Pittrof ◽  
Elizabeth Goodburn
Keyword(s):  
Risk Factors ◽  
Health Promotion ◽  
Cost Effectiveness ◽  
Reproductive Health ◽  
Sexual Health ◽  
Sexual And Reproductive Health ◽  
Health Clinics ◽  
Unknown Risk ◽  
Sexual Health Clinics ◽  
The Cost

The effectiveness of sexual behaviour change interventions in sexual health clinics is unknown. Risk factors for poor sexual and reproductive health such as depression, violence, alcohol and smoking in sexual health clinics are all common and can be identified easily in sexual health services. Targeting these risk factors could be as effective as traditional sexual health promotion and could have additional benefits. The authors propose a pilot to assess the cost-effectiveness and acceptability of incorporating screening and interventions for these risk factors.

scholarly journals The Role of Unknown Risk Factors in Myocardial Infarction

2013 ◽  
Vol 4 (6) ◽  
pp. 430
Author(s):  
Nita A Tanna ◽  
Rakesh Siyaram Srivastava ◽  
Vilpa Arvindbhai Tanna ◽  
Hetal Vithalbhai Vaishnani
Keyword(s):  
Risk Factors ◽  
Myocardial Infarction ◽  
Unknown Risk

scholarly journals The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil

2014 ◽  
Vol 2014 ◽  
pp. 1-13 ◽  
Author(s):  
Andrea M. Isidori ◽  
Giovanni Corona ◽  
Antonio Aversa ◽  
Daniele Gianfrilli ◽  
Emmanuele A. Jannini ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Cardiovascular Risk ◽  
Pulse Pressure ◽  
Real Life ◽  
Major Adverse Cardiovascular Event ◽  
Significant Rise ◽  
Total Testosterone ◽  
Adverse Cardiovascular Event ◽  
Real Life Setting ◽  
Unknown Risk

Increased cardiovascular risk has been associated with reduced response to proerectile drugs. The Italian Society of Andrology and Sexual Medicine (SIAMS) promoted an independent, multicenter study performed in 604 men (55 ± 12 yrs) suffering from erectile dysfunction (ED) to assess multiple health outcomes and response to 6-month vardenafil challenge in a real-life setting. Overall, 30.8% men had metabolic syndrome. Cardiovascular risk stratification revealed a greater number of ED subjects with moderate risk of a major adverse cardiovascular event than the general population (P<0.01). Age-adjusted pulse pressure was positively correlated with ED severity and negatively with androgens and waist circumference (P<0.01). A decline in total testosterone was observed with increasing arterial pulse pressure (P<0.05), which was not accompanied by compensatory LH rise. Follow-up on 185 men treated with vardenafil in an nonrandomized, open, single-arm trial documented a significant rise in IIEF-5 (delta = 6.1 ± 4.8) that was maintained in men with high cardiovascular risk. Mild adverse events occurred in <5%, with no differences between cardiovascular risk classes. In summary, ED is a frequent symptom in patients with an elevated, but often unknown, risk of future cardiovascular events. Androgens predict vascular resistance in ED patients. Vardenafil’s response and safety profile were preserved in subjects with higher cardiovascular risk.

Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study

2015 ◽  
Vol 75 (6) ◽  
pp. 1016-1023 ◽  
Author(s):  
Anna Moltó ◽  
Adrien Etcheto ◽  
Désirée van der Heijde ◽  
Robert Landewé ◽  
Filip van den Bosch ◽  
...  
Keyword(s):  
Risk Factors ◽  
Gastroduodenal Ulcer ◽  
International Study ◽  
Daily Practice ◽  
Systematic Evaluation ◽  
Cross Sectional ◽  
Unknown Risk ◽  
Increased Risk ◽  
High Prevalence ◽  
Cholesterol Measurement

BackgroundIncreased risk of some comorbidities has been reported in spondyloarthritis (SpA). Recommendations for detection/management of some of these comorbidities have been proposed, and it is known that a gap exists between these and their implementation in practice.ObjectiveTo evaluate (1) the prevalence of comorbidities and risk factors in different countries worldwide, (2) the gap between available recommendations and daily practice for management of these comorbidities and (3) the prevalence of previously unknown risk factors detected as a result of the present initiative.MethodsCross-sectional international study with 22 participating countries (from four continents), including 3984 patients with SpA according to the rheumatologist.Statistical analysisThe prevalence of comorbidities (cardiovascular, infection, cancer, osteoporosis and gastrointestinal) and risk factors; percentage of patients optimally monitored for comorbidities according to available recommendations and percentage of patients for whom a risk factor was detected due to this study.ResultsThe most frequent comorbidities were osteoporosis (13%) and gastroduodenal ulcer (11%). The most frequent risk factors were hypertension (34%), smoking (29%) and hypercholesterolaemia (27%). Substantial intercountry variability was observed for screening of comorbidities (eg, for LDL cholesterol measurement: from 8% (Taiwan) to 98% (Germany)). Systematic evaluation (eg, blood pressure (BP), cholesterol) during this study unveiled previously unknown risk factors (eg, elevated BP (14%)), emphasising the suboptimal monitoring of comorbidities.ConclusionsA high prevalence of comorbidities in SpA has been shown. Rigorous application of systematic evaluation of comorbidities may permit earlier detection, which may ultimately result in an improved outcome of patients with SpA.

scholarly journals Infertility Risk Factors and Nurse’s Role

2019 ◽  
Vol 3 (1) ◽  
pp. 1-8
Author(s):  
Arzu Abiç ◽  
Duygu Vefikuluçay Yılmaz
Keyword(s):  
Risk Factors ◽  
Healthy Lifestyle ◽  
Treatment Strategies ◽  
Lifestyle Behaviors ◽  
Factors Affecting ◽  
Care Plans ◽  
Individual Care ◽  
Unknown Risk ◽  
Time Problem ◽  
Reproductive Techniques

There are many known and unknown risk factors affecting fertility. Nowadays although infertility risk factors have been revealed with the researches carried out today, studies are still going on for many factors brought about by modern life. Nurses should be aware of risk factors that negatively affect fertility in order to prevent deterioration of fertility abilities of individuals. Infertility nurses should assess life-style behaviors in detail while taking anamnesis from couples who have fertility problems or apply for long-term and financially expensive treatment methods such as assisted reproductive techniques. In addition, nurses should do counseling to couples on lifestyles that have an impact on the fertility of individuals and follow the current literature on the subject. Especially risky lifestyle behaviors should be improved if there is no time problem for the couple. Otherwise, treatment strategies should be developed to change these behaviors and individual care plans should be provided to individuals about healthy lifestyle behaviors. In addition, nurses should train couples for risk factors. In this context, the risk factors causing the infertility and nursing roles will be discussed in our review. Key words: Ä°nfertilty, Risk Factors, Nursing, Role

Frostbite injury: an unknown risk when using nitrous oxide as a party drug

2020 ◽  
pp. 1-4
Author(s):  
Marcel Libertus Johannes Quax ◽  
Timothy Jason Van Der Steenhoven ◽  
Martinus Wilhelmus Gerardus Antonius Bronkhorst ◽  
Benjamin Lucas Emmink
Keyword(s):  
Nitrous Oxide ◽  
Unknown Risk

scholarly journals Unknown Risk on the Farm: Does Agricultural Use of Ionophores Contribute to the Burden of Antimicrobial Resistance?

mSphere ◽  
2019 ◽  
Vol 4 (5) ◽  
Author(s):  
Alex Wong
Keyword(s):  
Antimicrobial Resistance ◽  
Human Health ◽  
The United States ◽  
Evidence Base ◽  
Systematic Investigation ◽  
Current Evidence ◽  
Cross Resistance ◽  
Unknown Risk ◽  
Current Evidence Base ◽  
Agricultural Use

ABSTRACT Ionophores are the second most widely used class of antibiotic in agriculture, with over 4 million kilograms sold in the United States in 2016. Because ionophores are not used in humans, it is widely assumed that their agricultural use will not impact human health. Consequently, these drugs have not been subject to the same regulations as medically important antibiotics. Here, I argue that the current evidence base is insufficient to conclude that ionophores do not contribute to human relevant antimicrobial resistance. It is unclear whether ionophore resistance can result in cross-resistance to medically important antibiotics. Moreover, recent evidence suggests that ionophore use may coselect for resistance to vancomycin in some cases. Systematic investigation of the consequences of agricultural ionophore use for human health is therefore imperative.

Thrombin generation and venous thromboembolism

2008 ◽  
Vol 28 (01/02) ◽  
pp. 37-39 ◽  
Author(s):  
S. Eichinger
Keyword(s):  
At Risk ◽  
Venous Thromboembolism ◽  
Thrombin Generation ◽  
Recurrence Risk ◽  
Hormonal Contraceptives ◽  
Antithrombin Deficiency ◽  
Unknown Risk ◽  
Patients At Risk ◽  
Recurrent Venous Thrombosis

SummaryVenous thromboembolism is a chronic and potential fatal disease. Determination of recurrence risk is time-consuming and costly, and sometimes not feasible: many patients carry more than one risk factor, the relevance of some factors with regard to risk of recurrence is unknown, and existence of thus far unknown risk factors must be considered. A laboratory assay that measures multifactorial thrombophilia would be useful to identify patients at risk of thrombosis. The process of thrombin generation is the central event of the hemostatic process. Thrombin generation is increased in patients at risk of thrombosis including those with antithrombin deficiency or those who are taking hormonal contraceptives. Risk of first and recurrent venous thrombosis is higher in patients with increased thrombin generation. Thus, by use of a simple global marker of coagulation stratification of patients according to their risk of thrombosis is possible. Future studies are needed to improve the management of patients with VTE and increased thrombin generation.

Sign in / Sign up

Export Citation Format

Share Document